NOOTROPIC MEDICINAL AGENT

The invention relates to medicine, in particular to neurology and psychiatry and can be used in the form of an agent for normalising the physiological and functional activity of the central nervous system of a brain intellectually-mnestic function. The inventive medicinal agent exhibits a nootropic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GULYAEV, IVAN VALERYEVICH, SHVARTSMAN, IAKOV YUDELEVICH, MELNIKOVA, NINA BORISOVNA, YASHNOVA, OLGA KONSTANTINOVNA, PETRYAKOVA, OLGA VLADIMIROVNA
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to medicine, in particular to neurology and psychiatry and can be used in the form of an agent for normalising the physiological and functional activity of the central nervous system of a brain intellectually-mnestic function. The inventive medicinal agent exhibits a nootropic activity an comprises dimephosphone in the form of an active substance. Said medicinal agent is embodied in the form of an aqueous solution and also comprises citric acid and lithium carbonate at the following component ratio: 5.0-30.0 mass% dimephosphone, 0.5-5.0 mass % lithium carbonate, 3.0-4.0 mass % citric acid, the rest up to 100% being deionised water. The medicinal agent in the form of a syrup has the following component ratio: 3.0-5.0 mass% dimephosphone, 1.0-1.2 mass% lithium carbonate, 4.0-5.0 mass% citric acid and 89-92.0 mass% sixty-four percentage sugar syrup. A syrup having a high concentration of dimephosphone and a glycerin-containing syrup are also disclosed as the variants of the invention. Said medicinal agents have more physiological pH values exhibited within an extended range of concentrations, are characterized by the high dilution stability of the solutions thereof and have a delectable flavor, thereby easing the use thereof in a child treatment form.